Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density also can be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis.
A team of researchers has sequenced the genome of classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. The findings could pave the way to delivering personalized treatments.
Dr. Harold Varmus, director of the National Cancer Institute at the National Institutes of Health, is internationally recognized for his research on retroviruses and the genetic basis of cancer.
Dr. Silvia C. Formenti, an international expert in the use of radiation therapy for the treatment of cancer, has been appointed chair of the newly established Department of Radiation Oncology at Weill Cornell Medical College.
A team of researchers at Weill Cornell has improved a nonsurgical procedure that safely and effectively corrects newborn ear deformities in just two weeks.
With a new NIH grant, investigators in the Tuberculosis Research Unit hope to catalyze research findings made in the lab and at Weill Cornell's GHESKIO clinic in Haiti into new, effective agents to replace current TB therapies.
How much money would be saved if one high-risk person was prevented from contracting HIV in the United States? A new Weill Cornell study provides the answer.
In an exclusive symposium designed for Cornell students, officials from the United Nations detailed a new 15-year initiative on battling climate change worldwide.
Hundreds of Cornellians participated in a Big Red version of the "Antiques Road Show" Feb. 6 in New York City. Among the donated items is a piece of the goal post from Penn's Franklin Field taken down in the wake of a famous Cornell football win in 1958.
